Mission possible: AstraZeneca CEO Soriot rallies the troops, promising to fight on
“Together, we are poised to achieve something remarkable and that few thought possible. Nothing can break the momentum you have established, and certainly not rumors.”
Pascal Soriot chose those words to rally a badly rattled staff at AstraZeneca in a memo circulated earlier this week, according to a report from Reuters’ Ben Hirschler. Soriot followed up with a commitment to make an appearance at the European Society for Medical Oncology meeting in Madrid early September, if the global giant is ready to publish details of MYSTIC, the key combination study of durvalumab and tremelimumab that everyone is now waiting for.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.